The BioLymph study – implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results

Authors

  • K. E. Smedby a Dept of Hematology, Karolinska University Hospital Solna, Sweden; b Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden
  • T. Wästerlid a Dept of Hematology, Karolinska University Hospital Solna, Sweden; b Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden
  • E. Tham c Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; d Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden
  • Z. Haider c Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
  • J. Joelsson a Dept of Hematology, Karolinska University Hospital Solna, Sweden; b Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden
  • B. Thorvaldsdottir c Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
  • A. Krstic d Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden
  • B. E. Wahlin a Dept of Hematology, Karolinska University Hospital Solna, Sweden; e Dept of Medicine Huddinge, Karolinska Institutet
  • H. Foroughi-Asl
  • C. Karlsson a Dept of Hematology, Karolinska University Hospital Solna, Sweden; f Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
  • S. Eloranta b Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden
  • L. Saft f Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
  • M. Palma a Dept of Hematology, Karolinska University Hospital Solna, Sweden; f Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
  • A. Kwiecinska g Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden
  • L. Hansson a Dept of Hematology, Karolinska University Hospital Solna, Sweden; f Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
  • A. Österborg a Dept of Hematology, Karolinska University Hospital Solna, Sweden; f Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
  • V. Wirta h Science for Life Laboratory, Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; i Science for Life Laboratory, Royal Insititute of Technology, Stockholm, Sweden;j Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden
  • G. Rassidakis f Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; g Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden
  • B. Sander g Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden; k Dept of Laboratory Medicine, Karolinska Institutet Stockholm, Sweden
  • K. Sonnevi a Dept of Hematology, Karolinska University Hospital Solna, Sweden; e Dept of Medicine Huddinge, Karolinska Institutet
  • R. Rosenquist c Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;d Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden; j Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden

DOI:

https://doi.org/10.1080/0284186X.2023.2218556

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2023-06-03

How to Cite

Smedby, K. E., Wästerlid, T., Tham, E., Haider, Z., Joelsson, J., Thorvaldsdottir, B., … Rosenquist, R. (2023). The BioLymph study – implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results. Acta Oncologica, 62(6), 560–564. https://doi.org/10.1080/0284186X.2023.2218556

Issue

Vol. 62 No. 6 (2023): Acta Oncologica

Section

Articles